1Kikkawa F, Nawa A, Kajiyama H,et al.G Clinical characteristics andprognosis of mucinous tumors of the ovary. Gynecol Oncol, 2006, 103:171-175.
2Matsushita Y, Yokoyama Y, Taniguchi R, et al. A case of ovarianmucinous adenocarcinoma in a premenarcheal girl. Int J Clin Oncol,2012, 17:517-521.
3Hoerl HD, Hart WR. Primary ovarian mucinous cystadenocarcinomas:a clinicopathologic study of 49 cases with long-term follow-up. Am JSurg Pathol, 1998, 2: 1449-1462.
4Kelly PJ, Archbold P, Price JH, et al. Serum CA19.9 levels arecommonly elevated in primary ovarian mucinous tumours but cannotbe used to predict the histological subtype. J Clin Pathol, 2010, 63:169-173.
5Tahrizi AD, Kalloger SE, Kobel M, et al. Primary ovarian mucinouscarcinoma of intestinal type: significance of pattern of invasion andimmunohistochemical expression profile in a series of 31 cases. Int JGynecol Pathol, 2010, 29: 99-107.
6Fukazawa I, Inaba N, Ota Y, et al. Serum levels of six tumor markersin patients with benign and malignant gynecological disease. ArchGynecol Obstet, 1988, 243:61-68.
7Lo NS, Sarr MG. Mucinous cystadenocarcinoma of the appendix. Thecontroversy persists: a review. Hepatogastroenterology, 2003,50: 432-437.
9Kong KY, Park JY, Kim DY, et al. Prognostic significance of stromalmicroinvasion in the intestinal type of ovarian mucinousadenocarcinoma. Ann Surg Oncol, 2011, 18: 3462-3468.
